Tests biological activity of transition metal complexes in mixed-ligand scenarios, suggesting potential applications.
A new series of Ni (II), Zn (II), and Cu (II) mixed-ligand complexes of pentamethylenedithiocarbamate (pmdtc) with diamines such as ethylenediamine (en), diethylenetriamine (dien), and triethylenetetramine (trien) are reported. The synthesized complexes were characterized by elemental, thermal, and magnetic analyses, as well as UV–Visible, infrared (IR), Nuclear Magnetic Resonance (NMR), and Electron Spin Resonance (ESR) spectral studies. The antibacterial, antifungal, and anticancer activities of these complexes were also investigated. All the complexes exhibited reasonable biological activity, indicating a promising future for the mixed-ligand complexes of Ni (II), Zn (II), and Cu (II) in the biological field with potentially fewer side effects.
No takes yet. Share an insight, caveat, or question.
Kavitha Meenalochani Ramaswamy (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: